Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Stryker Corp (SYK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,570,816
  • Shares Outstanding, K 373,990
  • Annual Sales, $ 12,444 M
  • Annual Income, $ 1,020 M
  • 36-Month Beta 0.62
  • Price/Sales 5.07
  • Price/Cash Flow 20.32
  • Price/Book 6.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 1.68
  • Number of Estimates 13
  • High Estimate 1.70
  • Low Estimate 1.66
  • Prior Year 1.52
  • Growth Rate Est. (year over year) +10.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
163.16 +4.18%
on 07/31/18
177.37 -4.17%
on 07/18/18
-6.13 (-3.48%)
since 07/17/18
3-Month
162.29 +4.74%
on 06/12/18
179.84 -5.48%
on 06/07/18
-1.28 (-0.75%)
since 05/17/18
52-Week
137.70 +23.44%
on 08/23/17
179.84 -5.48%
on 06/07/18
+24.62 (+16.94%)
since 08/17/17

Most Recent Stories

More News
Ember Therapeutics Enters Into Agreement to Divest OP-1 Portfolio Program to Viscogliosi Brothers, LLC

Ember Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the clinical application of Bone Morphogenetic Protein-7 (BMP-7), announced today that it has entered into a letter of intent...

SYK : 169.98 (+0.76%)
EMBT : 0.3500 (+191.67%)
MDT : 90.60 (-0.55%)
Cardiovascular Systems Posts 2-Year LIBERTY 360 Study Data

The 24-month outcome of LIBERTY 360 study by Cardiovascular Systems (CSII) demonstrates a constant relief from major amputation across all Rutherford Classifications (RC).

SYK : 169.98 (+0.76%)
LNTH : 13.45 (-2.18%)
HAE : 103.51 (+0.18%)
CSII : 37.56 (+0.11%)
Market Trends Toward New Normal in ING Group, N.V, Altaba, Steel Dynamics, The TJX Companies, Colgate-Palmolive, and Stryker -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ING Group, N.V. (NYSE:ING),...

AABA : 68.17 (+0.04%)
ING : 13.35 (-0.22%)
TJX : 100.35 (+0.82%)
SYK : 169.98 (+0.76%)
CL : 67.50 (+1.17%)
STLD : 43.73 (+0.78%)
DENTSPLY (XRAY) Beats on Q2 Earnings, Lowers 2018 Guidance

DENTSPLY (XRAY) gains from solid year-over-year international revenue growth in Q2; high impairment charges in the quarter mars results.

SYK : 169.98 (+0.76%)
ILMN : 325.88 (-0.34%)
XRAY : 38.67 (+1.55%)
ISRG : 524.92 (+0.19%)
Medical Product Stock Earnings on Aug 6: CAH, HSIC & More

The Medical product market gains momentum owing to the recent two-year suspension of the controversial 2.3% Medical Device tax.

SYK : 169.98 (+0.76%)
HSIC : 80.34 (+1.48%)
BSX : 34.41 (+0.35%)
NXTM : 28.15 (-0.46%)
LMNX : 26.79 (+0.75%)
CAH : 51.90 (+2.87%)
Medical Robots Market to hit 21% CAGR and Projected to Reach US$ 16.74 Billion by 2023, led by Pharmaceutical and Healthcare Uses

PUNE, India, August 3, 2018 /PRNewswire/ --

HNSN : 3.99 (unch)
OMCL : 64.60 (+0.78%)
SYK : 169.98 (+0.76%)
ISRG : 524.92 (+0.19%)
Pacific Biosciences (PACB) Loss In Line With Estimates in Q2

Strong performance in Product revenues boosts Pacific Biosciences (PACB) in Q2. Sequel order improves year over year.

SYK : 169.98 (+0.76%)
PACB : 4.19 (-3.90%)
ILMN : 325.88 (-0.34%)
ISRG : 524.92 (+0.19%)
DexCom (DXCM) Beats Q2 Earnings Estimates, Raises '18 View

Solid contribution from the Sensor, Transmitter and Receiver segments drives DexCom's (DXCM) Q2 results.

SYK : 169.98 (+0.76%)
ILMN : 325.88 (-0.34%)
ISRG : 524.92 (+0.19%)
DXCM : 130.96 (+2.07%)
Integer Holdings (ITGR) Beats on Q2 Earnings, '18 View Solid

Integer Holdings (ITGR) gains on solid Cardio & Vascular revenues and high organic sales; a solid guidance raises optimism.

ITGR : 71.45 (+0.92%)
SYK : 169.98 (+0.76%)
ILMN : 325.88 (-0.34%)
ISRG : 524.92 (+0.19%)
DaVita (DVA) Beats Earnings and Revenue Estimates in Q2

Year-over-year growth in net dialysis and related lab patient service revenues boost DaVita's (DVA) bottom line in Q2.

SYK : 169.98 (+0.76%)
ILMN : 325.88 (-0.34%)
ISRG : 524.92 (+0.19%)
DVA : 72.49 (-0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade SYK with:

Business Summary

Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital...

See More

Key Turning Points

2nd Resistance Point 171.85
1st Resistance Point 170.92
Last Price 169.98
1st Support Level 168.34
2nd Support Level 166.69

See More

52-Week High 179.84
Last Price 169.98
Fibonacci 61.8% 163.74
Fibonacci 50% 158.77
Fibonacci 38.2% 153.80
52-Week Low 137.70

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar